Pasar al contenido principal

PAPEL DE BAMBI EN EL CONTROL DE LAS RESPUESTAS INMUNE HUMORALES Y EN INMUNIDAD DE MUCOSAS. IDENTIFICACION DE UNA NUEVA DIANA TERAPEUTICA EN INFLAMACION

SAF2014-55088-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bone morphogenetic protein and activin membrane-bound inhibitor, a transforming growth factor β rheostat that controls murine treg cell/Th17 cell differentiation and the development of autoimmune arthritis by reducing interleukin-2 signaling

  • Postigo, Jorge
  • Iglesias, Marcos
  • Álvarez, Pilar
  • Augustin, Juan Jesús
  • Buelta, Luis
  • Merino, Jesús
  • Merino, Ramón
[Objective]: Transforming growth factor β (TGFβ) plays a prominent role in the establishment of immunologic tolerance, and mice lacking TGFβ1 die of multiorgan inflammation early in life. TGFβ controls the differentiation of CD4+ lymphocytes into Treg cells or proinflammatory Th17 cells. Although this dual capacity is modulated by the presence of additional cytokines around the activated cells, TGFβ also dissociates Th17/Treg cell differentiation in a dose-dependent manner by mechanisms still unknown. The purpose of this study was to explore the contribution of bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) to the modulation of TGFβ activity during the differentiation of CD4+ cells and in the control of immunologic tolerance in mice with collagen-induced arthritis (CIA). [Methods]: The in vitro and in vivo Treg cell and Th17 cell differentiation and the development of CIA were compared in wild-type mice and BAMBI-deficient mice. [Results]: BAMBI was induced after activation by TGFβ and fixed the appropriate intensity level of TGFβ signaling in CD4+ cells. Its deficiency protected mice against the development of CIA by a Treg cell- and TGFβ-dependent mechanism. Mechanistically, BAMBI was found to regulate CD25 expression and interleukin-2 (IL-2) signaling in Treg cells and in IL-2- and/or TGFβ-activated CD4+ cells and modulated Treg cell and Th17 cell differentiation both in vitro and in vivo. [Conclusion]: Taken together, the results indicate that BAMBI is a component of a rheostat-like mechanism that, through the control of TGFβ and IL-2 signaling strength, regulates the differentiation of CD4+ lymphocytes and the development of autoimmune arthritis., Supported by grants from the Spanish Ministerio de Economía y Competitividad (SAF2012-34059 to Dr. J. Merino and SAF2011-22463 and SAF2014-55088-R to Dr. R. Merino), which were cofunded by the European Regional Development Fund. Dr. Iglesias’ work was supported in part by a grant from the Spanish Ministerio de Economía y Competitividad (IPT2011-1527-010000) in association with FibroStatin SL., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective impairment of TH17-differentiation and protection against autoimmune arthritis after overexpression of BCL2A1 in T lymphocytes

  • Iglesias, Marcos
  • Augustin, Juan Jesús
  • Álvarez, Pilar
  • Santiuste, Inés
  • Postigo, Jorge
  • Merino, Jesús
  • Merino, Ramón
The inhibition of apoptotic cell death in T cells through the dysregulated expression of BCL2 family members has been associated with the protection against the development of different autoimmune diseases. However, multiple mechanisms were proposed to be responsible for such protective effect. The purpose of this study was to explore the effect of the T-cell overexpression of BCL2A1, an anti-apoptotic BCL2 family member without an effect on cell cycle progression, in the development of collagen-induced arthritis. Our results demonstrated an attenuated development of arthritis in these transgenic mice. The protective effect was unrelated to the suppressive activity of regulatory T cells but it was associated with a defective activation of p38 mitogen-activated protein kinase in CD4 cells after in vitro TCR stimulation. In addition, the in vitro and in vivo T17 differentiation were impaired in BCL2A1 transgenic mice. Taken together, we demonstrated here a previously unknown role for BCL2A1 controlling the activation of CD4 cells and their differentiation into pathogenic proinflammatory T17 cells and identified BCL2A1 as a potential target in the control of autoimmune/inflammatory diseases., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad to RM (SAF2011-22463 and SAF2014-55088-R) and JM (SAF2012-34059), which were co-funded by the European Regional Development Fund. MI was partially supported by a grant from the Spanish Ministerio de Economía y Competitividad (IPT2011- 1527-010000) associated with Fibrostatin SL., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD6 modulates thymocyte selection and peripheral T cell homeostasis

  • Orta-Mascaró, Marc
  • Álvarez, Pilar
  • Merino, Ramón
  • Martínez, Vanesa G.
  • Merino, Jesús
  • Lozano, Francisco
Orta-Mascaró et al., The CD6 glycoprotein is a lymphocyte surface receptor putatively involved in T cell development and activation. CD6 facilitates adhesion between T cells and antigen-presenting cells through its interaction with CD166/ALC AM (activated leukocyte cell adhesion molecule), and physically associates with the T cell receptor (TCR) at the center of the immunological synapse. However, its precise role during thymocyte development and peripheral T cell immune responses remains to be defined. Here, we analyze the in vivo consequences of CD6 deficiency. CD6-/- thymi showed a reduction in both CD4 and CD8 single-positive subsets, and double-positive thymocytes exhibited increased Ca2 mobilization to TCR cross-linking in vitro. Bone marrow chimera experiments revealed a T cell-autonomous selective disadvantage of CD6-/- T cells during development. The analysis of TCR-transgenic mice (OT-I and Marilyn) confirmed that abnormal T cell selection events occur in the absence of CD6. CD6-/- mice displayed increased frequencies of antigen-experienced peripheral T cells generated under certain levels of TCR signal strength or co-stimulation, such as effector/memory (CD4TEM and CD8TCM) and regulatory (T reg) T cells. The suppressive activity of CD6-/- T reg cells was diminished, and CD6-/- mice presented an exacerbated autoimmune response to collagen. Collectively, these data indicate that CD6 modulates the threshold for thymocyte selection and the generation and/or function of several peripheral T cell subpopulations, including T reg cells., This work is supported by grants from: Worldwide Cancer Research (14-1275) and Fundació La Marató TV3 (201319-30) to F. Lozano; Spanish Ministerio de Economía y Competitividad (Plan Nacional I+D+i) co-financed by European Development Regional Fund “A way to achieve Europe” to F. Lozano (SAF2013-46151-R), J. Merino (SAF2012-34059), R. Merino (SAF2014-55088-R), and R. Vicente (SAF2014- 52228-R); IPT2011-1527-010000 (associated to Fibrostatin SL) to J. Merino; and Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, European Research Council (FP7/2007–2013 grant no. 322465), and ANR grant Basilic to B. Malissen and M. Malissen. M. Orta-Mascaró, I. Simões, and E. Carreras are recipients of fellowships from Ministerio de Economía y Competitividad (BES-2011-048415), Fundação para a Ciência e a Tecnologia (SFRH/ BD/75738/2011), and European Community Seventh Framework Program (BIOTRACK, FP7/2007/2013;229673), respectively. National Institutes of Health grants to Velocigene at Regeneron Inc. (U01HG004085), and the CSD Consortium (U01HG004080) funded the generation of gene-targeted vectors and ES cells for 8,500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and CHORI (U42RR024244)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol

  • Álvarez, Pilar
  • Genre, Fernanda
  • Iglesias, Marcos
  • Augustin, Juan Jesús
  • Tamayo, Esther
  • Escolà-Gil, Joan Carles
  • Lavín, Bernardo
  • Blanco-Vaca, Francisco
  • Merino, Ramón
  • Merino, Jesús
Apolipoprotein E (ApoE) deficiency promoted an exacerbation of autoimmune arthritis in mice by inducing proinflammatory immune responses. In this study we analysed the contribution of hypercholesterolaemia and/or the absence of ApoE anti-inflammatory properties, unrelated to its function in the control of cholesterol metabolism, towards the acceleration of arthritis in these mutant animals. The induction and severity of collagen type II-induced arthritis (CIA) were compared for B10.RIII wild-type (WT), B10.RIII.ApoE, B10.RIII.ApoE and B10.RIII.low-density lipoprotein receptor (LDLR) mice with different concentrations of circulating ApoE and cholesterol. A 50–70% reduction in serum levels of ApoE was observed in heterozygous B10.RIII.ApoE mice in comparison to B10.RIII.WT, although both strains of mice exhibited similar circulating lipid profiles. This ApoE reduction was associated with an increased CIA severity that remained lower than in homozygous B10.RIII.ApoE mice. An important rise in circulating ApoE concentration was observed in hypercholesterolaemic B10.RIII.LDLR mice fed with a normal chow diet, and both parameters increased further with an atherogenic hypercholesterolaemic diet. However, the severity of CIA in B10.RIII.LDLR mice was similar to that of B10.RIII.WT controls. In conclusion, by comparing the evolution of CIA between several strains of mutant mice with different levels of serum ApoE and cholesterol, our results demonstrate that both hypercholesterolaemia and ApoE regulate the intensity of in-vivo systemic autoimmune responses., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad to J. M. (SAF2012‐34059) and R. M. (SAF2014‐55088‐R), which were co‐funded by the European Regional Development Fund. M. I. was supported partially by a grant from the Spanish Ministerio de Economía y Competitividad (IPT2011‐1527‐010000) associated with fibrostatin SL., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Context-dependent regulation of Th17-associated genes and IFNγ expression by the transcription factor NFAT5

  • Alberdi, Maria
  • Iglesias, Marcos
  • Tejedor, Sonia
  • Merino, Ramón
  • López-Rodríguez, Cristina
  • Aramburu, Jose
Stress-activated transcription factors influence T-cell function in different physiopathologic contexts. NFAT5, a relative of nuclear factor κB and the calcineurin-activated NFATc transcription factors, protects mammalian cells from hyperosmotic stress caused by the elevation of extracellular sodium levels. In T cells exposed to hypernatremia, NFAT5 not only induces osmoprotective gene products but also cytokines and immune receptors, which raises the question of whether this factor could regulate other T-cell functions in osmostress-independent contexts. Here we have used mice with a conditional deletion of Nfat5 in mature T lymphocytes to explore osmostress-dependent and -independent functions of this factor. In vitro experiments with CD4 T cells stimulated in hyperosmotic medium showed that NFAT5 enhanced the expression of IL-2 and the Th17-associated gene products RORγt and IL-23R. By contrast, NFAT5-deficient CD4 T cells activated in vivo by anti-CD3 antibody exhibited a different activation profile and were skewed towards enhanced interferon γ (IFNγ) and IL-17 expression and attenuated Treg responses. Using a model of experimental colitis, we observed that mice lacking NFAT5 in T cells exhibited exacerbated intestinal colitis and enhanced expression of IFNγ in draining lymph nodes and colon. These results show that NFAT5 can modulate different T-cell responses depending on stress conditions and stimulatory context., JA was funded by the Spanish Ministry of Economy and Competitiveness (SAF2011-24268, cofunded by the European Regional Development Fund), and Fundació la Marató TV3 (122530). CL-R was funded by the Spanish Ministry of Economy and Competitiveness (SAF2012-36535, SAF2015-71363-R, cofunded by the European Regional Development Fund). CL-R is a recipient of an ICREA Acadèmia award from Institució Catalana de Recerca i Estudis Avançats (ICREA, Generalitat de Catalunya). JA and CL-R also acknowledge funding support from Generalitat de Catalunya (2009SGR601, 2014SGR1153) and the Spanish Ministry of Economy and Competitiveness, through the 'María de Maeztu' Program for Units of Excellence in R&D (MDM-2014-0370). RM was funded by the Spanish Ministry of Economy and Competitiveness (SAF2011-22463 and SAF2014-55088-R, cofunded by the European Regional Development Fund). MA was supported by predoctoral fellowships from Generalitat de Catalunya (FI-DGR program 2009) and the Spanish Ministry of Education, Culture and Sports (FPU program, AP2010-5411). MI was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (IPT2011-1527-010000). ST is the recipient of a predoctoral fellowship of the Spanish Ministry of Economy and Competitiveness (BES-2013-062670)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice

  • Rueda, Noemí
  • Vidal, Verónica
  • García-Cerro, Susana
  • Narcís, Josep Oriol
  • Llorens-Martín, María
  • Corrales, Andrea
  • Lantigua, Sara
  • Iglesias, Marcos
  • Merino, Jesús
  • Merino, Ramón
  • Martínez-Cué, Carmen
Down syndrome (DS) is characterized by structural and functional anomalies that are present prenatally and that lead to intellectual disabilities. Later in life, the cognitive abilities of DS individuals progressively deteriorate due to the development of Alzheimer's disease (AD)-associated neuropathology (i.e., β-amyloid (Aβ) plaques, neurofibrillary tangles (NFTs), neurodegeneration, synaptic pathology, neuroinflammation and increased oxidative stress). Increasing evidence has shown that among these pathological processes, neuroinflammation plays a predominant role in AD etiopathology. In AD mouse models, increased neuroinflammation appears earlier than Aβ plaques and NFTs, and in DS and AD models, neuroinflammation exacerbates the levels of soluble and insoluble Aβ species, favoring neurodegeneration. The Ts65Dn (TS) mouse, the most commonly used murine model of DS, recapitulates many alterations present in both DS and AD individuals, including enhanced neuroinflammation. In this study, we observed an altered neuroinflammatory milieu in the hippocampus of the TS mouse model. Pro-inflammatory mediators that were elevated in the hippocampus of this model included pro-inflammatory cytokine IL17A, which has a fundamental role in mediating brain damage in neuroinflammatory processes. Here, we analyzed the ability of an anti-IL17A antibody to reduce the neuropathological alterations that are present in TS mice during early neurodevelopmental stages (i.e., hippocampal neurogenesis and hypocellularity) or that are aggravated in later-life stages (i.e., cognitive abilities, cholinergic neuronal loss and increased cellular senescence, APP expression, Aβ peptide expression and neuroinflammation). Administration of anti-IL17 for 5 months, starting at the age of 7 months, partially improved the cognitive abilities of the TS mice, reduced the expression of several pro-inflammatory cytokines and the density of activated microglia and normalized the APP and Aβ levels in the hippocampi of the TS mice. These results suggest that IL17-mediated neuroinflammation is involved in several AD phenotypes in TS mice and provide a new therapeutic target to reduce these pathological characteristics., This study was supported by the Jerome Lejeune Foundation, Fundación Tatiana Pérez de Guzmán el Bueno, the Spanish Ministry of Economy and Competitiveness (PSI-2016-76194-R, SAF2014-55088-R, SAF2017-82905-R, SAF2016-75195-R, AEI/FEDER, EU) and Luchamos por la Vida Foundation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol

  • Alvarez, Pilar
  • Genre, Fernanda|||0000-0003-3612-1448
  • Iglesias, Marcos
  • Augustín Rodríguez, Juan Jesús
  • Tamayo, Esther
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Lavín Gómez, Bernardo|||0000-0001-7279-7643
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Merino Pérez, Ramón|||0000-0002-5306-0635
  • Merino Pérez, Jesús|||0000-0003-3476-1150
Apolipoprotein E (ApoE) deficiency promoted an exacerbation of autoimmune arthritis in mice by inducing proinflammatory immune responses. In this study we analysed the contribution of hypercholesterolaemia and/or the absence of ApoE anti-inflammatory properties, unrelated to its function in the control of cholesterol metabolism, towards the acceleration of arthritis in these mutant animals. The induction and severity of collagen type II-induced arthritis (CIA) were compared for B10.RIII wild-type (WT), B10.RIII.ApoE, B10.RIII.ApoE and B10.RIII.low-density lipoprotein receptor (LDLR) mice with different concentrations of circulating ApoE and cholesterol. A 50-70% reduction in serum levels of ApoE was observed in heterozygous B10.RIII.ApoE mice in comparison to B10.RIII.WT, although both strains of mice exhibited similar circulating lipid profiles. This ApoE reduction was associated with an increased CIA severity that remained lower than in homozygous B10.RIII.ApoE mice. An important rise in circulating ApoE concentration was observed in hypercholesterolaemic B10.RIII.LDLR mice fed with a normal chow diet, and both parameters increased further with an atherogenic hypercholesterolaemic diet. However, the severity of CIA in B10.RIII.LDLR mice was similar to that of B10.RIII.WT controls. In conclusion, by comparing the evolution of CIA between several strains of mutant mice with different levels of serum ApoE and cholesterol, our results demonstrate that both hypercholesterolaemia and ApoE regulate the intensity of in-vivo systemic autoimmune responses.